News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
374,235 Results
Type
Article (26497)
Company Profile (166)
Press Release (347569)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (94401)
Career Advice (827)
Deals (17792)
Drug Delivery (109)
Drug Development (48070)
Employer Resources (63)
FDA (10743)
Job Trends (8539)
News (175591)
Policy (21156)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1908)
Academic (1)
Accelerated approval (33)
Adcomms (30)
Allergies (116)
Alliances (26249)
ALS (134)
Alzheimer's disease (1017)
Antibody-drug conjugate (ADC) (209)
Approvals (10917)
Artificial intelligence (367)
Autoimmune disease (116)
Automation (25)
Bankruptcy (117)
Best Places to Work (7753)
BIOSECURE Act (15)
Biosimilars (166)
Biotechnology (118)
Bladder cancer (136)
Brain cancer (35)
Breast cancer (425)
Cancer (3437)
Cardiovascular disease (338)
Career advice (722)
Career pathing (19)
CAR-T (186)
CDC (51)
Celiac Disease (1)
Cell therapy (555)
Cervical cancer (21)
Clinical research (42265)
Collaboration (1258)
Company closure (2)
Compensation (520)
Complete response letters (66)
COVID-19 (1797)
CRISPR (87)
C-suite (599)
Cystic fibrosis (117)
Data (4786)
Decentralized trials (1)
Denatured (23)
Depression (102)
Diabetes (363)
Diagnostics (3657)
Digital health (30)
Diversity (9)
Diversity, equity & inclusion (16)
Drug discovery (195)
Drug pricing (160)
Drug shortages (29)
Duchenne muscular dystrophy (177)
Earnings (35681)
Editorial (50)
Employer branding (6)
Employer resources (61)
Events (54524)
Executive appointments (613)
FDA (13073)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (8)
Frontotemporal dementia (18)
Funding (947)
Gene editing (173)
Generative AI (34)
Gene therapy (520)
GLP-1 (713)
Government (3813)
Grass and pollen (7)
Guidances (258)
Healthcare (11224)
HIV (52)
Huntington's disease (42)
IgA nephropathy (65)
Immunology and inflammation (140)
Immuno-oncology (51)
Indications (102)
Infectious disease (1993)
Inflammatory bowel disease (157)
Inflation Reduction Act (7)
Influenza (80)
Intellectual property (138)
Interviews (140)
IPO (9769)
IRA (34)
Job creations (1212)
Job search strategy (614)
JPM (40)
Kidney cancer (15)
Labor market (38)
Layoffs (272)
Leadership (18)
Legal (3743)
Liver cancer (59)
Longevity (11)
Lung cancer (492)
Lymphoma (304)
Machine learning (29)
Management (22)
Manufacturing (578)
MASH (122)
Medical device (6095)
Medtech (6122)
Mergers & acquisitions (8778)
Metabolic disorders (952)
mRNA (103)
Multiple sclerosis (131)
NASH (20)
Neurodegenerative disease (227)
Neuropsychiatric disorders (58)
Neuroscience (1960)
NextGen: Class of 2026 (3300)
Non-profit (2388)
Now hiring (17)
Obesity (470)
Opinion (168)
Ovarian cancer (111)
Pain (146)
Pancreatic cancer (144)
Parkinson's disease (215)
Partnered (16)
Patents (299)
Patient recruitment (341)
Peanut (43)
People (31284)
Pharmaceutical (38)
Pharmacy benefit managers (19)
Phase 1 (12020)
Phase 2 (17742)
Phase 3 (15786)
Pipeline (4145)
Policy (258)
Postmarket research (1777)
Preclinical (4780)
Press Release (21)
Prostate cancer (193)
Psychedelics (34)
Radiopharmaceuticals (217)
Rare diseases (708)
Real estate (2695)
Recruiting (27)
Regulatory (17238)
Reports (25)
Research institute (1702)
Resumes & cover letters (122)
Rett syndrome (28)
RNA editing (11)
RSV (57)
Schizophrenia (111)
Series A (161)
Series B (128)
Service/supplier (1)
Sickle cell disease (85)
Special edition (14)
Spinal muscular atrophy (111)
Sponsored (24)
Startups (1832)
Stomach cancer (13)
Supply chain (72)
Tariffs (77)
The Weekly (57)
Vaccines (734)
Venture capital (66)
Weight loss (318)
Women's health (59)
Worklife (5)
Date
Last 7 days (472)
Last 30 days (1808)
Last 365 days (19412)
2026 (3611)
2025 (19466)
2024 (21741)
2023 (24208)
2022 (31905)
2021 (34684)
2020 (32647)
2019 (27272)
2018 (20077)
2017 (18584)
2016 (16928)
2015 (19274)
2014 (14120)
2013 (11973)
2012 (12727)
2011 (13040)
2010 (10438)
Location
Africa (444)
Alabama (40)
Alaska (2)
Arizona (103)
Arkansas (5)
Asia (24802)
Australia (3628)
California (6674)
Canada (1968)
China (808)
Colorado (249)
Connecticut (314)
Delaware (265)
Europe (63182)
Florida (956)
Georgia (227)
Hawaii (1)
Idaho (29)
Illinois (545)
India (48)
Indiana (382)
Iowa (9)
Japan (376)
Kansas (73)
Kentucky (15)
Louisiana (19)
Maine (31)
Maryland (912)
Massachusetts (5226)
Michigan (124)
Minnesota (267)
Mississippi (1)
Missouri (79)
Montana (17)
Nebraska (13)
Nevada (61)
New Hampshire (26)
New Jersey (2292)
New Mexico (15)
New York (1991)
North Carolina (901)
North Dakota (6)
Northern California (3409)
Ohio (232)
Oklahoma (7)
Oregon (29)
Pennsylvania (1367)
Puerto Rico (10)
Rhode Island (29)
South America (573)
South Carolina (31)
Southern California (2539)
Tennessee (78)
Texas (984)
United States (24830)
Utah (204)
Vermont (1)
Virginia (196)
Washington D.C. (48)
Washington State (583)
West Virginia (1)
Wisconsin (73)
Wyoming (2)
374,235 Results for "european medicines agency ema".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
December 29, 2025
·
10 min read
Press Releases
IntraBio Receives Positive European Medicines Agency Opinion for Orphan Medicinal Product Designation for Acetylleucine for CACNA1A Disorders
February 25, 2026
·
2 min read
Press Releases
Neurona Therapeutics Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to NRTX-1001 in the Treatment of Drug-Resistant Focal Epilepsy
November 5, 2025
·
4 min read
Press Releases
ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia
February 24, 2026
·
10 min read
Press Releases
Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union
October 20, 2025
·
5 min read
Press Releases
AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union (EU)
December 3, 2025
·
5 min read
Press Releases
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease
February 26, 2026
·
12 min read
Press Releases
Affinia Therapeutics Receives European Medicines Agency Orphan Drug Designation for AFTX-201 in BAG3-Associated Dilated Cardiomyopathy (DCM)
February 18, 2026
·
3 min read
Press Releases
European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
February 27, 2026
·
6 min read
Press Releases
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
January 8, 2026
·
8 min read
1 of 37,424
Next
